Sign in to continue:

Saturday, February 14th, 2026

IHH Healthcare Berhad Director Mehmet Ali Aydinlar Disposes 856,800 Shares Outside Closed Period (Dec 2025)

IHH Healthcare Berhad: Director’s Share Disposal – Key Details for Investors

IHH Healthcare Berhad: Director’s Significant Share Disposal – Key Details for Investors

Overview of the Transaction

IHH Healthcare Berhad has announced a notable transaction involving one of its Non-Executive Directors, Mr. Mehmet Ali Aydinlar. On 04 December 2025, Mr. Aydinlar disposed of 856,800 ordinary shares in IHH Healthcare Berhad. This transaction was conducted outside the closed period, providing transparency to the market and its shareholders.

Key Details of the Share Disposal

  • Director Involved: Mehmet Ali Aydinlar (Non-Executive Director)
  • Type of Transaction: Disposal of ordinary shares
  • Date of Transaction: 04 December 2025
  • Number of Shares Disposed: 856,800
  • Percentage of IHH Total Shares: 0.010%
  • Consideration: MYR 8.312 per share

Updated Shareholdings Post-Transaction

After the disposal, Mr. Aydinlar’s shareholding in IHH Healthcare Berhad is as follows:

  • Direct Interest:
    • Citigroup Nominees (Asing) Sdn Bhd, nominee of UBS Switzerland AG: 7,000,000 ordinary shares
    • Citigroup Nominees (Asing) Sdn Bhd, UBS Switzerland AG for Mehmet Ali Aydinlar: 948,000 ordinary shares
  • Indirect Interest:
    • Citigroup Nominees (Asing) Sdn Bhd, nominee of UBS Switzerland AG: 7,000,000 ordinary shares
    • Raffles Nominees (Pte) Limited: 207,620,000 ordinary shares
    • Citigroup Nominees (Asing) Sdn Bhd, UBS Switzerland AG for SZA Gayrimenkul Yatirim Insaat ve Ticaret Anonim Sirketi: 304,403,473 ordinary shares

Why This Matters for Shareholders

Shareholder and Market Impact: Director dealings are closely watched by investors as they can signal insider views on the company’s prospects. The disposal of shares by a non-executive director, especially of this volume and value (MYR 8.312 per share), could be interpreted in several ways:

  • It may indicate the director’s personal financial planning or rebalancing.
  • It could potentially raise questions about the director’s outlook on the company’s future performance.
  • Large disposals, even when they represent a small percentage of the overall shareholding, may create short-term market reactions and affect investor sentiment.
  • The transaction was done outside the closed period, so there is no indication of immediate price sensitivity due to blackout rules, but investors should monitor any further movement or statements from the company.

Market Sensitivity: While the percentage of shares disposed is relatively small (0.010%), the absolute number is significant. Investors should keep an eye on continued director trades and any related disclosures from IHH Healthcare Berhad, as these could influence share price and trading volumes.

Conclusion

Director share disposals are important events for investors to monitor. Any change in ownership by a key member of the board can have short-term and long-term implications for the company’s stock performance and investor confidence.


Disclaimer: This article is for informational purposes only and does not constitute investment advice. Investors should conduct their own due diligence and consult with their advisors before making any investment decisions based on director dealings or other disclosures.


View IHH Historical chart here



SGX Group Achieves Record Highs in January 2026: Stock Market, ETF, Derivatives, and Commodities Performance Surge

SGX Group Achieves Record Growth in January 2026: Key Drivers and Price-Sensitive Developments SGX Group Achieves Record Growth in January 2026: Key Drivers and Price-Sensitive Developments Singapore Exchange (SGX Group) has begun 2026 with...

Lincotrade & Associates Receives SGX-ST Approval for S$0.22 Placement of 10 Million New Shares

Key Highlights Proposed Placement: Up to 10,000,000 new ordinary shares to be issued at S\$0.22 per share. SGX-ST Approval: The Singapore Exchange Securities Trading Limited (SGX-ST) has issued the listing and quotation notice for...

Salt Investments Limited Announces FY2025 AGM Voting Results and Resolutions Passed on 29 September 2025 12

SALT Investments AGM: Overwhelming Approval of FY2025 Resolutions Signals Strong Shareholder Confidence SALT Investments AGM: Overwhelming Approval of FY2025 Resolutions Signals Strong Shareholder Confidence Key Highlights from SALT Investments Limited’s Annual General Meeting for...

   Ad